Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 3/2016

06.07.2016 | Mini Review

The impact of glycemic variability on diabetic peripheral neuropathy

verfasst von: Heung Yong Jin, Kyung Ae Lee, Tae Sun Park

Erschienen in: Endocrine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Mean glucose values alone cannot explain the patterns of morbidity and mortality due to dysglycemia in diabetes. Development of continuous glucose monitoring systems has improved the analysis and interpretation of glycemic variability. The roles of glycemic components other than constant hyperglycemia in diabetic complications must be investigated because large clinical studies have indicated that risk factors besides the average glucose value of HbA1c are involved in chronic macrocomplications/microcomplications of diabetes. Among these complications, the pathogenesis of diabetic peripheral neuropathy is particularly complex, and several factors related to glucose and nonglucose pathways have been suggested as risk factors. There is little information regarding the effect of glycemic variability on diabetic peripheral neuropathy, unlike other microvascular complications of retinopathy and nephropathy, and whether glycemic variability causes harmful effects is still a matter of debate. In this review, we discuss the relationships between glycemic variability and diabetic peripheral neuropathy, focusing on somatosensory peripheral neuropathies rather than autonomic neuropathies.
Literatur
1.
W. Clarke, B. Kovatchev, Statistical tools to analyze continuous glucose monitor data. Diabetes Technol. Ther. 11(Suppl 1) S45–S54 (2009)PubMed
2.
H.S. Jung, Clinical implications of glucose variability: chronic complications of diabetes. Endocrinol. Metab. (Seoul) 30(2), 167–174 (2015)CrossRef
3.
J. Schlichtkrull, O. Munck, M. Jersild, M-value, an index for blood sugar control in diabetics. Ugeskr. Laeger. 126, 815–820 (1964)PubMed
4.
F.J. Service, G.D. Molnar, J.W. Rosevear, E. Ackerman, L.C. Gatewood, W.F. Taylor, Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19(9), 644–655 (1970)CrossRefPubMed
5.
K.D. Kohnert, P. Heinke, L. Vogt, E. Salzsieder, Utility of different glycemic control metrics for optimizing management of diabetes. World J. Diabetes 6(1), 17–29 (2015)CrossRefPubMedPubMedCentral
6.
7.
S. Yagihashi, H. Mizukami, K. Sugimoto, Mechanism of diabetic neuropathy: where are we now and where to go?. J. Diabetes Investig. 2(1), 18–32 (2011)CrossRefPubMed
8.
F. Garcia Soriano, L. Virag, P. Jagtap, E. Szabo, J.G. Mabley, L. Liaudet, A. Marton, D.G. Hoyt, K.G. Murthy, A.L. Salzman, G.J. Southan, C. Szabo, Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med. 7(1), 108–113 (2001)CrossRefPubMed
9.
R.J. Heine, B. Balkau, A. Ceriello, S. Del Prato, E.S. Horton, M.R. Taskinen, What does postprandial hyperglycaemia mean?. Diabet. Med. 21(3), 208–213 (2004)CrossRefPubMed
10.
A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, J.Y. Park, G.L. King, F.W. LoGerfo, E.S. Horton, A. Veves, Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48(9), 1856–1862 (1999)CrossRefPubMed
11.
S. Thrainsdottir, R.A. Malik, L.B. Dahlin, P. Wiksell, K.F. Eriksson, I. Rosen, J. Petersson, D.A. Greene, G. Sundkvist, Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 52(10), 2615–2622 (2003)CrossRefPubMed
12.
R. Stavniichuk, V.R. Drel, H. Shevalye, I. Vareniuk, M.J. Stevens, J.L. Nadler, I.G. Obrosova, Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radic. Biol. Med. 49(6), 1036–1045 (2010)CrossRefPubMedPubMedCentral
13.
S. Tesfaye, N. Chaturvedi, S.E. Eaton, J.D. Ward, C. Manes, C. Ionescu-Tirgoviste, D.R. Witte, J.H. Fuller, E.P.C.S. Group, Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352(4), 341–350 (2005)CrossRefPubMed
14.
R.M. Herman, J.B. Brower, D.G. Stoddard, A.R. Casano, J.H. Targovnik, J.H. Herman, P. Tearse, Prevalence of somatic small fiber neuropathy in obesity. Int. J. Obes. (Lond) 31(2), 226–235 (2007)CrossRef
15.
A.G. Smith, K. Rose, J.R. Singleton, Idiopathic neuropathy patients are at high risk for metabolic syndrome. J. Neurol. Sci. 273(1-2), 25–28 (2008)CrossRefPubMedPubMedCentral
16.
L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, A. Ceriello, Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52(11), 2795–2804 (2003)CrossRefPubMed
17.
M.J. Kim, H.S. Jung, Y. Hwang-Bo, S.W. Cho, H.C. Jang, S.Y. Kim, K.S. Park, Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta. Diabetol. 50(4), 505–510 (2013)CrossRefPubMed
18.
A. Ceriello, K. Esposito, L. Piconi, M.A. Ihnat, J.E. Thorpe, R. Testa, M. Boemi, D. Giugliano, Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57(5), 1349–1354 (2008)CrossRefPubMed
19.
L. Monnier, C. Colette, D.R. Owens, Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab. Res. Rev. 25(5), 393–402 (2009)CrossRefPubMed
20.
E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, For debate. Glucose variability and diabetes complication risk: we need to know the answer. Diabet. Med. 27(8), 868–871 (2010)CrossRefPubMed
21.
L. Quagliaro, L. Piconi, R. Assaloni, R. Da Ros, A. Maier, G. Zuodar, A. Ceriello, Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183(2), 259–267 (2005)CrossRefPubMed
22.
S. Kalopita, S. Liatis, P. Thomakos, I. Vlahodimitris, C. Stathi, N. Katsilambros, N. Tentolouris, K. Makrilakis, Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes. J. Diabetes Res. 2014, 835392 (2014)CrossRefPubMedPubMedCentral
23.
J.E. Jun, S.M. Jin, J. Baek, S. Oh, K.Y. Hur, M.S. Lee, M.K. Lee, J.H. Kim, The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc. Diabetol. 14, 70 (2015)CrossRefPubMedPubMedCentral
24.
25.
S.E. Siegelaar, E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, J.B. Hoekstra, J.H. Devries, Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 52(10), 2229–2232 (2009)CrossRefPubMedPubMedCentral
26.
J. Bragd, U. Adamson, L.B. Backlund, P.E. Lins, E. Moberg, P. Oskarsson, Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?. Diabetes Metab. 34(6 Pt 1), 612–616 (2008)CrossRefPubMed
27.
J. Soupal, J. Skrha Jr. M. Fajmon, E. Horova, M. Mraz, J. Skrha, M. Prazny, Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control. Diabetes Technol. Ther. 16(4), 198–203 (2014)CrossRefPubMed
28.
F. Xu, L.H. Zhao, J.B. Su, T. Chen, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, X.H. Wang, The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab. Syndr. 6(1), 139 (2014)CrossRefPubMedPubMedCentral
29.
S.O. Oyibo, Y.D. Prasad, N.J. Jackson, E.B. Jude, A.J. Boulton, The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet. Med. 19(10), 870–873 (2002)CrossRefPubMed
30.
S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R.A. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Toronto Diabetic Neuropathy Expert, G.: diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10), 2285–2293 (2010)CrossRefPubMedPubMedCentral
31.
X. Meng, C. Gong, B. Cao, X. Peng, D. Wu, Y. Gu, L. Wei, X. Liang, M. Liu, W. Li, C. Su, Glucose fluctuations in association with oxidative stress among children with T1DM: comparison of different phases. J. Clin. Endocrinol. Metab. 100(5), 1828–1836 (2015)CrossRefPubMed
32.
K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, D. Giugliano, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106(16), 2067–2072 (2002)CrossRefPubMed
33.
K.D. Kohnert, P. Augstein, P. Heinke, E. Zander, K. Peterson, E.J. Freyse, E. Salzsieder, Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res. Clin. Pract. 77(3), 420–426 (2007)CrossRefPubMed
34.
N. Colomo, M.J. Tapia, M.R. Vallejo, F. Garcia-Torres, E. Rubio-Martin, F.F. Caballero, J.M. Jimenez, M.J. Pelaez, A.M. Gomez, I. Sanchez, J.P. Lopez-Siguero, F. Soriguer, M.S. Ruiz de Adana, Glycemic variability and oxidative stress in children, with type 1 diabetes attending a summer camp. An Pediatr (Barc) 81(3), 174–180 (2014)CrossRef
35.
E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 31(11), 2198–2202 (2008)CrossRefPubMedPubMedCentral
36.
Y. Kitahara, K. Miura, K. Takesue, T. Mine, R. Wada, Y. Uchida, S. Ito, S. Yagihashi, Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes. Metabolism 51(11), 1452–1457 (2002)CrossRefPubMed
37.
R.J. Strilka, M.C. Stull, M.S. Clemens, S.C. McCaver, S.B. Armen, Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia. Theor. Biol. Med. Model 13, 3 (2016)CrossRefPubMedPubMedCentral
38.
M. Kuroda, T. Shinke, K. Sakaguchi, H. Otake, T. Takaya, Y. Hirota, D. Sugiyama, M. Nakagawa, H. Hariki, T. Inoue, T. Osue, Y. Taniguchi, M. Iwasaki, R. Nishio, H. Kinutani, A. Konishi, N. Hiranuma, H. Takahashi, D. Terashita, K. Hirata, Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC Cardiovasc. Interv. 8(6), 800–811 (2015)CrossRefPubMed
39.
D.J. Zdarska, M. Kvapil, Z. Rusavy, M. Krcma, J. Broz, B. Krivska, P. Kadlecova, Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: the COBIN2 study. Wien. Klin. Wochenschr. 126(7-8), 228–237 (2014)CrossRefPubMed
40.
S.E. Olsen, M.R. Bjorgaas, B.O. Asvold, T. Sand, M. Stjern, B.M. Frier, K.B. Nilsen, Impaired awareness of hypoglycemia in adults with type 1 diabetes is not associated with autonomic dysfunction or peripheral neuropathy. Diabetes Care 39(3), 426–433 (2016)CrossRefPubMed
Metadaten
Titel
The impact of glycemic variability on diabetic peripheral neuropathy
verfasst von
Heung Yong Jin
Kyung Ae Lee
Tae Sun Park
Publikationsdatum
06.07.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1005-7

Weitere Artikel der Ausgabe 3/2016

Endocrine 3/2016 Zur Ausgabe

Erratum

Erratum to: The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines

Research Letter

Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly

Research Letter

Association between thyroid function tests and anti-thyroid peroxidase (TPO) antibodies in pregnancy

Original Article

Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing’s syndrome

Original Article

Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?

Original Article

Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise